A successful pregnancy and uncomplicated labor with C1INH concentrate prophylaxis in a patient with hereditary angioedema

Allergologia et Immunopathologia

Volumn 35, Issue 3, 2007, Pages 117-119

  Caliskaner, Z ^a   Ozturk, S ^a   Gulec, M ^a   Dede, M ^a   Erel, F ^a   Karaayvaz, M ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Hereditary angioedema; Pregnancy

Indexed keywords

ANTIHISTAMINIC AGENT; COMPLEMENT COMPONENT C1S INHIBITOR; CORTICOSTEROID DERIVATIVE; DANAZOL;

ADULT; ANAMNESIS; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; FOLLOW UP; HUMAN; LABOR MANAGEMENT; LABORATORY TEST; MATERNAL MORTALITY; PATIENT DECISION MAKING; PREGNANCY;

EID: 34547865004     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1157/13106781     Document Type: Article

References (6)

1. Gompels MM, Lock RJ, Abinun M, Bethune CA, Davies G, Grattan C, Fay AC, Longhurst HJ, Morrison L, Price A, Price M, Watters D. C1 inhibitor deficiency: consensus document. Clin Exp Immunol. 2005;139:379-94.
2. rd. The pathogenesis of hereditary angioedema. Transfus Apher Sci. 2003;29:195-203.
3. Visy B, Füst G, Varga L, Szendei G, Takács E, Karádi I, et al. Sex hormones in hereditary angioneurotic oedema. Clinical Endocrinology. 2004;60:508-15
4. Galan HL, Reedy MB, Starr J, Knight AB. Fresh frozen plasma prophylaxis for hereditary angioedema during pregnancy. A case report. J Reprod Med. 1996;41:541-4.
5. De Serres J, Groner A, Lindner J. Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert P) in hereditary angioedema: a review. Transfus Apher Sci. 2003;29:247-54.
6. Kunschak M, Engl W, Maritsch F, Rosen FS, Eder G, Zerlauth G, Schwarz HP. A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema. Transfusion. 1998;38:540-549.